Should You Buy Lumexa Imaging Holdings, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Lumexa Imaging Holdings, Inc. (LMRI) scores 3.5/10 on our Quality of Company framework, indicating mixed operational fundamentals. At the current price of $11.77, our multi-model valuation analyzes whether the market has already discounted these weaknesses.
The short answer: 2 of 2 CirclFi valuation models project upside for Lumexa Imaging Holdings, Inc. (LMRI) at $11.77 — the model consensus leans bullish, with a Quality Score of 3.5/10 and Value-Trap risk of 0/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Lumexa Imaging Holdings, Inc. (LMRI) in 2026?
What Is the Bull Case vs the Bear Case for Lumexa Imaging Holdings, Inc. (LMRI)?
| Bull case — $27.06 target (+129.9%) | Bear case |
|---|---|
| According to the CirclFi Deep Alpha Valuation Engine, the gap between the market price of $11.77 and the median fair value of $21.17 implies +79.8% upside potential. | No active model flags significant downside for LMRI. The low Value Trap score paints a constructive picture. |
| According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model targets a fair value of $27.06 (+129.9%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | |
| Industry tailwind: regulatory pathway clarity could provide meaningful support for Lumexa Imaging Holdings, Inc.'s revenue and margin trajectory in the Medical Devices space. |
How Does LMRI Compare to Its Medical Devices Peers?
Valuation data pages: GCTK · RTGN · ODYY · WOK · STME · BDMD · AXGN · RDGL · NXL · IRMD · PODD
Which Other Stocks Score Like LMRI on Quality?
Closest companies to LMRI’s Quality of Company score of 3.5/10, across all industries.
- OXLC — Oxford Lane Capital Corp. (QOC 3.5) · analysis
- SUND — Sundance Strategies, Inc. (QOC 3.5) · analysis
- BTGO — BitGo Holdings, Inc. (QOC 3.5) · analysis
- SKFG — Stark Focus Group, Inc. (QOC 3.5) · analysis
- ATMH — All Things Mobile Analytic Inc. (QOC 3.5) · analysis
- GMTL — Guardian Metal Resources PLC (QOC 3.5) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Medical Devices Screens Does LMRI Appear In?
So Is Lumexa Imaging Holdings, Inc. (LMRI) Worth Buying in 2026?
The convergence of 3.5/10 quality, multi-model undervaluation (2/2 bullish, +79.8% median upside), and a median fair value of $21.17 vs. $11.77 current price makes Lumexa Imaging Holdings, Inc. one of the more compelling opportunities in our coverage. As always, our models provide a quantitative starting point — not a substitute for individual due diligence.
These are quantitative model outputs, not investment recommendations. Lumexa Imaging Holdings, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About LMRI Stock?
Should I buy LMRI stock right now?
Based on CirclFi's multi-model analysis, 2 of 2 models see upside for LMRI at $11.77. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 3.5/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Lumexa Imaging Holdings, Inc.?
Key risks include: a below-average Quality Score of 3.5/10, indicating fundamental weakness; limited model coverage (2/13 active), reducing analytical confidence; general market and sector-specific risks affecting Medical Devices companies. Always diversify and consult a financial advisor.
How does LMRI compare to its competitors?
Among Medical Devices peers, LMRI holds a Quality Score of 3.5/10. Comparable companies include GCTK (QOC 3.6), RTGN (QOC 3.5), ODYY (QOC 3.7). The relative ranking helps investors identify whether LMRI offers better fundamental quality than alternatives in the same sector.
Is LMRI a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. LMRI's Quality Score of 3.5/10 raises concerns about long-term viability without significant operational improvements. Check our full data page for all 13 model estimates.
What price should I buy LMRI at?
CirclFi does not provide target buy prices or price alerts. However, our 2 active models produce fair value estimates ranging from $15.28 to $27.06. At $11.77, the stock trades below even the most conservative estimate, which may represent a margin of safety — or reflect risks the models don't capture. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for LMRI.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad